Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Helicobacter pylori pathogenicity and primary antimicrobial resistance in Northern Spain.

Fernández-Reyes M, Tamayo E, Rojas-Rengifo D, Fischer W, Carrasco-García E, Alonso M, Lizasoain J, Bujanda L, Cosme Á, Montes M.

Eur J Clin Invest. 2019 Jun 13:e13150. doi: 10.1111/eci.13150. [Epub ahead of print]

PMID:
31192451
2.

Therapeutic relevance of SOX9 stem cell factor in gastric cancer.

Carrasco-Garcia E, Álvarez-Satta M, García-Puga M, Ribeiro ML, Arevalo S, Arauzo-Bravo M, Matheu A.

Expert Opin Ther Targets. 2019 Feb;23(2):143-152. doi: 10.1080/14728222.2019.1559826. Epub 2018 Dec 20.

PMID:
30572738
3.

PDGFR and IGF-1R Inhibitors Induce a G2/M Arrest and Subsequent Cell Death in Human Glioblastoma Cell Lines.

Carrasco-Garcia E, Martinez-Lacaci I, Mayor-López L, Tristante E, Carballo-Santana M, García-Morales P, Ventero Martin MP, Fuentes-Baile M, Rodriguez-Lescure Á, Saceda M.

Cells. 2018 Sep 6;7(9). pii: E131. doi: 10.3390/cells7090131.

4.

Towards precision medicine: linking genetic and cellular heterogeneity in gastric cancer.

Carrasco-Garcia E, García-Puga M, Arevalo S, Matheu A.

Ther Adv Med Oncol. 2018 Aug 29;10:1758835918794628. doi: 10.1177/1758835918794628. eCollection 2018. Review.

5.

SOX2 expression diminishes with ageing in several tissues in mice and humans.

Carrasco-Garcia E, Moreno-Cugnon L, Garcia I, Borras C, Revuelta M, Izeta A, Lopez-Lluch G, de Pancorbo MM, Vergara I, Vina J, Matheu A.

Mech Ageing Dev. 2019 Jan;177:30-36. doi: 10.1016/j.mad.2018.03.008. Epub 2018 Mar 21.

PMID:
29574045
6.

Integrin α7: a novel promising target in glioblastoma stem cells.

Carrasco-Garcia E, Auzmendi-Iriarte J, Matheu A.

Stem Cell Investig. 2018 Jan 13;5:2. doi: 10.21037/sci.2017.12.05. eCollection 2018. No abstract available.

7.

Oncogenic activity of SOX1 in glioblastoma.

Garcia I, Aldaregia J, Marjanovic Vicentic J, Aldaz P, Moreno-Cugnon L, Torres-Bayona S, Carrasco-Garcia E, Garros-Regulez L, Egaña L, Rubio A, Pollard S, Stevanovic M, Sampron N, Matheu A.

Sci Rep. 2017 Apr 20;7:46575. doi: 10.1038/srep46575.

8.

Increased Arf/p53 activity in stem cells, aging and cancer.

Carrasco-Garcia E, Moreno M, Moreno-Cugnon L, Matheu A.

Aging Cell. 2017 Apr;16(2):219-225. doi: 10.1111/acel.12574. Epub 2017 Jan 19. Review.

9.

Targeting SOX2 as a Therapeutic Strategy in Glioblastoma.

Garros-Regulez L, Garcia I, Carrasco-Garcia E, Lantero A, Aldaz P, Moreno-Cugnon L, Arrizabalaga O, Undabeitia J, Torres-Bayona S, Villanua J, Ruiz I, Egaña L, Sampron N, Matheu A.

Front Oncol. 2016 Oct 24;6:222. eCollection 2016. Review.

10.

SOX9 Elevation Acts with Canonical WNT Signaling to Drive Gastric Cancer Progression.

Santos JC, Carrasco-Garcia E, Garcia-Puga M, Aldaz P, Montes M, Fernandez-Reyes M, de Oliveira CC, Lawrie CH, Araúzo-Bravo MJ, Ribeiro ML, Matheu A.

Cancer Res. 2016 Nov 15;76(22):6735-6746. doi: 10.1158/0008-5472.CAN-16-1120. Epub 2016 Aug 28.

11.

SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin.

Carrasco-Garcia E, Lopez L, Aldaz P, Arevalo S, Aldaregia J, Egaña L, Bujanda L, Cheung M, Sampron N, Garcia I, Matheu A.

Sci Rep. 2016 Aug 30;6:32350. doi: 10.1038/srep32350.

12.

Inflammaging and Frailty Status Do Not Result in an Increased Extracellular Vesicle Concentration in Circulation.

Alberro A, Sáenz-Cuesta M, Muñoz-Culla M, Mateo-Abad M, Gonzalez E, Carrasco-Garcia E, Araúzo-Bravo MJ, Matheu A, Vergara I, Otaegui D.

Int J Mol Sci. 2016 Jul 20;17(7). pii: E1168. doi: 10.3390/ijms17071168.

13.

Paradoxical role of SOX2 in gastric cancer.

Carrasco-Garcia E, Santos JC, Garcia I, Brianti M, García-Puga M, Pedrazzoli J Jr, Matheu A, Ribeiro ML.

Am J Cancer Res. 2016 Mar 15;6(4):701-13. eCollection 2016. Review.

14.

mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.

Garros-Regulez L, Aldaz P, Arrizabalaga O, Moncho-Amor V, Carrasco-Garcia E, Manterola L, Moreno-Cugnon L, Barrena C, Villanua J, Ruiz I, Pollard S, Lovell-Badge R, Sampron N, Garcia I, Matheu A.

Expert Opin Ther Targets. 2016;20(4):393-405. doi: 10.1517/14728222.2016.1151002.

15.

Increased gene dosage of Ink4/Arf and p53 delays age-associated central nervous system functional decline.

Carrasco-Garcia E, Arrizabalaga O, Serrano M, Lovell-Badge R, Matheu A.

Aging Cell. 2015 Aug;14(4):710-4. doi: 10.1111/acel.12343. Epub 2015 May 20.

16.

Comparative Study of 17-AAG and NVP-AUY922 in Pancreatic and Colorectal Cancer Cells: Are There Common Determinants of Sensitivity?

Mayor-López L, Tristante E, Carballo-Santana M, Carrasco-García E, Grasso S, García-Morales P, Saceda M, Luján J, García-Solano J, Carballo F, de Torre C, Martínez-Lacaci I.

Transl Oncol. 2014 Oct 24;7(5):590-604. doi: 10.1016/j.tranon.2014.08.001. eCollection 2014 Oct.

17.

Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation.

Grasso S, Tristante E, Saceda M, Carbonell P, Mayor-López L, Carballo-Santana M, Carrasco-García E, Rocamora-Reverte L, García-Morales P, Carballo F, Ferragut JA, Martínez-Lacaci I.

Neoplasia. 2014 Oct 23;16(10):845-60. doi: 10.1016/j.neo.2014.08.011. eCollection 2014 Oct.

18.

Role of receptor tyrosine kinases and their ligands in glioblastoma.

Carrasco-García E, Saceda M, Martínez-Lacaci I.

Cells. 2014 Apr 4;3(2):199-235. doi: 10.3390/cells3020199.

19.

Therapeutic strategies targeting glioblastoma stem cells.

Carrasco-Garcia E, Sampron N, Aldaz P, Arrizabalaga O, Villanua J, Barrena C, Ruiz I, Arrazola M, Lawrie C, Matheu A.

Recent Pat Anticancer Drug Discov. 2013 Sep;8(3):216-27. Review.

PMID:
23607282
20.

Study of the anticancer properties of tin(IV) carboxylate complexes on a panel of human tumor cell lines.

Rocamora-Reverte L, Carrasco-García E, Ceballos-Torres J, Prashar S, Kaluđerović GN, Ferragut JA, Gómez-Ruiz S.

ChemMedChem. 2012 Feb 6;7(2):301-10. doi: 10.1002/cmdc.201100432. Epub 2011 Dec 13.

PMID:
22170592
21.

Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines.

Carrasco-García E, Saceda M, Grasso S, Rocamora-Reverte L, Conde M, Gómez-Martínez A, García-Morales P, Ferragut JA, Martínez-Lacaci I.

Exp Cell Res. 2011 Jun 10;317(10):1476-89. doi: 10.1016/j.yexcr.2011.03.015. Epub 2011 Apr 1.

PMID:
21439954
22.

Protein kinase C-alpha antagonizes apoptosis induction by histone deacetylase inhibitors in multidrug resistant leukaemia cells.

Castro-Galache MD, Menéndez-Gutiérrez MP, Carrasco Garcia E, Garcia-Morales P, Martinez-Lacaci I, Saceda M, Ferragut JA.

Int J Biochem Cell Biol. 2007;39(10):1877-85. Epub 2007 May 21.

PMID:
17588800
23.

Post-transcriptional regulation of P-glycoprotein expression in cancer cell lines.

Gómez-Martínez A, García-Morales P, Carrato A, Castro-Galache MD, Soto JL, Carrasco-García E, García-Bautista M, Guaraz P, Ferragut JA, Saceda M.

Mol Cancer Res. 2007 Jun;5(6):641-53.

24.

Inhibition of Hsp90 function by ansamycins causes downregulation of cdc2 and cdc25c and G(2)/M arrest in glioblastoma cell lines.

García-Morales P, Carrasco-García E, Ruiz-Rico P, Martínez-Mira R, Menéndez-Gutiérrez MP, Ferragut JA, Saceda M, Martínez-Lacaci I.

Oncogene. 2007 Nov 8;26(51):7185-93. Epub 2007 May 21.

PMID:
17525741
25.

Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells.

García-Morales P, Hernando E, Carrasco-García E, Menéndez-Gutierrez MP, Saceda M, Martínez-Lacaci I.

Mol Cancer Ther. 2006 Sep;5(9):2172-81.

26.

Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines.

García-Morales P, Gómez-Martínez A, Carrato A, Martínez-Lacaci I, Barberá VM, Soto JL, Carrasco-García E, Menéndez-Gutierrez MP, Castro-Galache MD, Ferragut JA, Saceda M.

Mol Cancer Ther. 2005 Aug;4(8):1222-30.

27.

Differentiation and drug resistance relationships in leukemia cells.

Camarasa MV, Castro-Galache MD, Carrasco-García E, Garcia-Morales P, Saceda M, Ferragut JA.

J Cell Biochem. 2005 Jan 1;94(1):98-108.

PMID:
15517594

Supplemental Content

Loading ...
Support Center